New methods to help bones heal in people with inflammatory arthritis
Novel approaches to promote healing of bone loss in inflammatory arthritis
This study is looking for new ways to help people with rheumatoid arthritis heal their bones better by blocking a protein that stops bone growth, and it aims to see if this treatment can improve bone health for those affected by the condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Massachusetts Med Sch Worcester NIH-funded |
| Lab location | 1 site (Worcester, United States) |
| Project ID | NIH-11042707 on NIH RePORTER |
What this research studies
This research focuses on developing new treatments to promote bone healing in patients with rheumatoid arthritis (RA), a condition that causes significant bone loss. The study investigates the role of a specific protein, Schnurri-3 (SHN3), which inhibits bone formation, and aims to inhibit this protein to enhance bone-building cells. By using a specialized viral vector to target SHN3, the researchers hope to prevent or treat bone loss associated with RA. Patients will be monitored to assess the effectiveness of this approach in improving bone health.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with rheumatoid arthritis who are experiencing bone loss.
Not a fit: Patients without rheumatoid arthritis or those who do not have significant bone loss may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that significantly improve bone health and reduce complications for patients with rheumatoid arthritis.
How similar studies have performed: Previous research has shown promising results in targeting similar pathways for bone health, indicating potential for success in this novel approach.
Where this research is happening
Worcester, United States
- Univ of Massachusetts Med Sch Worcester — Worcester, United States (Active)
Researchers
- Principal investigator: Shim, Jae-Hyuck — Univ of Massachusetts Med Sch Worcester
- Study coordinator: Shim, Jae-Hyuck
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.